<?xml version="1.0" encoding="UTF-8"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-10-19T01:06:15Z</responseDate><request verb="GetRecord" identifier="oai:ebyu-rdlopen.rawdatalibrary.net:ebyu/13391" metadataPrefix="oai_dc">https://ebyu-rdlopen.rawdatalibrary.net/oai/request</request><GetRecord><record><header><identifier>oai:ebyu-rdlopen.rawdatalibrary.net:ebyu/13391</identifier><datestamp>2026-10-18T20:33:51Z</datestamp><setSpec>openaire</setSpec><setSpec>driver</setSpec><setSpec>com_ebyu_10000</setSpec><setSpec>col_ebyu_10001</setSpec></header><metadata><oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd"><dc:title>Antioxidant, antiepileptic, and anticholinergic properties of 4′,5,7-Trihydroxy-3,6-dimethoxyflavone as natural phenolic compound: a toxicology approach</dc:title><dc:creator>Durmaz, Lokman</dc:creator><dc:subject>4′,5,7-Trihydroxy-3,6-dimethoxyflavone</dc:subject><dc:subject>acetylcholinesterase</dc:subject><dc:subject>antioxidant activity</dc:subject><dc:subject>enzyme inhibition</dc:subject><dc:subject>metabolic enzymes</dc:subject><dc:subject>4',5,7 trihydroxy 3,6 dimethoxyflavone</dc:subject><dc:subject>acetazolamide</dc:subject><dc:subject>alpha tocopherol</dc:subject><dc:subject>anticonvulsive agent</dc:subject><dc:subject>antioxidant</dc:subject><dc:subject>butylated hydroxyanisole</dc:subject><dc:subject>butylcresol</dc:subject><dc:subject>carbonate dehydratase I</dc:subject><dc:subject>carbonate dehydratase II</dc:subject><dc:subject>cholinergic receptor blocking agent</dc:subject><dc:subject>cholinesterase</dc:subject><dc:subject>copper</dc:subject><dc:subject>cupric ion</dc:subject><dc:subject>ferric ion</dc:subject><dc:subject>ferrous ion</dc:subject><dc:subject>isoenzyme</dc:subject><dc:subject>natural product</dc:subject><dc:subject>phenol derivative</dc:subject><dc:subject>trolox C</dc:subject><dc:subject>unclassified drug</dc:subject><dc:subject>ABTS radical scavenging assay</dc:subject><dc:subject>analytic method</dc:subject><dc:subject>anticonvulsant activity</dc:subject><dc:subject>antioxidant assay</dc:subject><dc:subject>Article</dc:subject><dc:description>In this work, the antioxidant properties of 4′,5,7-trihydroxy-3,6-dimethoxyflavone using several bioanalytical assays is investigated in vitro. These methods are Cu2+-Cu+ reducing, Fe3+-Fe2+reducing, DPPH• scavenging, and ABTS•+ scavenging. The IC50 values of the 4′,5,7-trihydroxy-3,6-dimethoxyflavone for DPPH• and ABTS•+ scavenging assays were 9.36 and 3.55 μg m–1, respectively. Additionally, 4′,5,7-trihydroxy-3,6-dimethoxyflavone compound recorded best inhibitory effects against human carbonic anhydrase (hCA) I and II isoenzymes, acetylcholinesterase (AChE), and butyrylcholinesterase (BChE) enzymes. 4′,5,7-Trihydroxy-3,6-dimethoxyflavone had K i value of 389.56 ± 29 nM against hCA I and 306.90 ± 41 nM toward hCA II, respectively. Also, the K i values of AChE and BChE were found as 1005.37 ± 117 nM and 814.22 ± 87 nM, respectively. © 2019 Informa UK Limited, trading as Taylor &amp; Francis Group.</dc:description><dc:publisher>Taylor and Francis Ltd.</dc:publisher><dc:date>2021</dc:date><dc:type>Article</dc:type><dc:identifier>https://rdlopen.rawdatalibrary.net/r/ebyu/13391</dc:identifier><dc:identifier>https://doi.org/10.1080/15569543.2019.1610894</dc:identifier><dc:identifier>1556-9543</dc:identifier><dc:language>en</dc:language><dc:relation>Toxin Reviews</dc:relation><dc:rights>info:eu-repo/semantics/openAccess</dc:rights><dc:type>info:eu-repo/semantics/article</dc:type><dc:identifier>https://ebyu-rdlopen.rawdatalibrary.net/tr/items/ebyu/13391</dc:identifier></oai_dc:dc></metadata></record></GetRecord></OAI-PMH>